NOVAVAX INC Shares Authorized
NOVAVAX INC (NVAX) had Shares Authorized of 600.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares Authorized 600.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 600.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 600.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 600.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 600.00M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 600.00M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 600.00M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 600.00M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 600.00M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 600.00M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 600.00M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 600.00M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 600.00M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 600.00M shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 600.00M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 600.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 600.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 600.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 600.00M shares 10-K · filed 2024-02-28 |
| 2022-09-30 | 600.00M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 600.00M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 600.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 600.00M shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 600.00M shares 10-Q · filed 2021-11-05 |
| 2021-06-30 | 600.00M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 600.00M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 600.00M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 600.00M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 600.00M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 600.00M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 600.00M shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 600.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 600.00M shares 10-Q · filed 2019-08-07 |
| 2019-05-10 | 600.00M shares 10-K · filed 2021-03-01 |
| 2019-03-31 | 600.00M shares 10-Q · filed 2019-05-02 |
| 2018-12-31 | 600.00M shares 10-K · filed 2020-03-11 |
| 2018-09-30 | 600.00M shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 600.00M shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 600.00M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 600.00M shares 10-K · filed 2019-03-18 |
| 2017-09-30 | 600.00M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 600.00M shares 10-Q · filed 2017-08-08 |
| 2017-03-31 | 600.00M shares 10-Q · filed 2017-05-08 |
| 2016-12-31 | 600.00M shares 10-K · filed 2018-03-14 |
| 2016-09-30 | 600.00M shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 600.00M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 600.00M shares 10-Q · filed 2016-05-05 |
| 2015-12-31 | 600.00M shares 10-K · filed 2017-02-27 |
| 2015-09-30 | 600.00M shares 10-Q · filed 2015-11-09 |
| 2015-06-30 | 600.00M shares 10-Q · filed 2015-08-10 |
| 2015-03-31 | 300.00M shares 10-Q · filed 2015-05-07 |
| 2014-12-31 | 300.00M shares 10-K · filed 2016-02-29 |
| 2014-09-30 | 300.00M shares 10-Q · filed 2014-11-06 |
| 2014-06-30 | 300.00M shares 10-Q · filed 2014-08-07 |
| 2014-03-31 | 300.00M shares 10-Q · filed 2014-05-08 |
| 2013-12-31 | 300.00M shares 10-K · filed 2015-02-27 |
| 2013-09-30 | 300.00M shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 300.00M shares 10-Q · filed 2013-08-08 |
| 2013-03-31 | 200.00M shares 10-Q · filed 2013-05-09 |
| 2012-12-31 | 200.00M shares 10-K · filed 2014-03-12 |
| 2012-09-30 | 200.00M shares 10-Q · filed 2012-11-09 |
| 2012-06-30 | 200.00M shares 10-Q · filed 2012-08-09 |
| 2012-03-31 | 200.00M shares 10-Q · filed 2012-05-09 |
| 2011-12-31 | 200.00M shares 10-K · filed 2013-03-12 |
| 2011-09-30 | 200.00M shares 10-Q · filed 2011-11-08 |
| 2011-06-30 | 200.00M shares 10-Q · filed 2011-08-09 |
| 2010-12-31 | 200.00M shares 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |